Although we have not yet formally tested the effects of IL-18 alone or IL-18+IL-12 in conjunction with NKT14m, future studies are warranted to explore these combination treatments to broaden the modalities for iNKT cell-based cellular immunotherapy for cancer. This evidence concerns the gene IL18 and cancer.